CELLPHIRE

Cellphire is actively seeking partners within industry and academia to evaluate applications for stabilized cellular therapies in a wide range of clinical, therapeutic, and diagnostic fields... Cellphire Therapeutics is a biotechnology company focused on developing pooled allogeneic cellular therapy products to save lives. Our lead product, Thrombosomes® is in Phase 2 clinical trials... Through our veterinary subsidiary, BodeVet®, we developed and launched the company's first commercially available product, StablePlate RX® Canine, a canine freeze-dried platelet product with demonstrated efficacy in stopping bleeding in dogs. We are developing additional innovative transfusion medicine therapies for companion animals, including freeze-dried canine plasma. BodeVet® is also expanding its platelet work to support equine patients, as well as exotic animals such as elephants.

Also known as: Cellphire Therapeutics, Cellphire Therapeutics, Inc., Cellphire, Inc.

Primary location: Rockville United States